{"schema_version":"1","generated_at":"2026-11-03T22:27:44.314Z","data_as_of":null,"url":"https://www.findmykol.com/kol/alexander-hindenburg","json_url":"https://www.findmykol.com/kol/alexander-hindenburg/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"alexander-hindenburg","name":"Alexander Hindenburg","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Mineola","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1285684175","orcid":"0000-0002-1232-2168","openalex":"A5108031174"},"summary":"Alexander Hindenburg is an Oncology physician. OpenAlex indexes 61 publications with 2,206 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":61,"cited_by_count":2206,"h_index":19,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00960401","title":"A Study of Atherosclerosis in Patients After Radiation Treatment for Breast Cancer","status":"COMPLETED","role":"Overall official","sponsor":"Winthrop University Hospital","source_url":"https://clinicaltrials.gov/study/NCT00960401","trial_url":"https://www.findmykol.com/trial/NCT00960401"}],"source":"trials"},"payments":{"company_count":12,"program_years":{"first":2021,"last":null},"rows_total":16,"shown":3,"withheld":13,"rows":[{"payer":"Astellas Pharma US Inc","program_year":2025,"amount_usd":31.34,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285684175"},{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":15.76,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285684175"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2024,"amount_usd":47.72,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285684175"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1285684175","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":96.6,"classes_total":4,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":67.6,"drugs":[{"name":"Letrozole","share_pct":66.5},{"name":"Exemestane","share_pct":17.2},{"name":"Anastrozole","share_pct":16.3}],"max_beneficiaries":59},{"class":"Estrogen Agonist/Antagonist","setting":"prescribed","share_pct":13.1,"drugs":[{"name":"Tamoxifen Citrate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Sensory organs","share_pct":3.4,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":3.4,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":94,"facility_pct":6},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Real-world evaluation of therapeutic anticoagulation for cancer-associated thromboembolism: A retrospective analysis","year":2025,"journal":"Journal of Oncology Pharmacy Practice","source_url":"https://doi.org/10.1177/10781552251331559","status":"verified"},{"title":"Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19","year":2023,"journal":"JAMA","source_url":"https://doi.org/10.1001/jama.2023.3651","status":"verified"},{"title":"Safety and efficacy of oral anticoagulants in extreme weights","year":2023,"journal":"Thrombosis Research","source_url":"https://doi.org/10.1016/j.thromres.2023.09.001","status":"verified"},{"title":"Abstract PD9-08: ImPrint immune signature in 10,000 early-stage breast cancer patients from the real-world FLEX database","year":2023,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.sabcs22-pd9-08","status":"verified"},{"title":"Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 Pandemic","year":2022,"journal":"The Oncologist","source_url":"https://doi.org/10.1093/oncolo/oyab042","status":"verified"}],"source":"works"},"contact":{"address_1":"120 MINEOLA BLVD STE 500","city":"Mineola","state":"NY","zip":"115014074","phone":"516-663-9500","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1285684175","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":13,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-03-03","provider_certified":"2021-03-03","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}